Heron Therapeutics
(HRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 46,575 | 144,583 | 65,524 | 30,277 | 83,513 |
| Marketable Securities | 67,363 | 27,796 | 8,492 | 78,986 | 81,703 |
| Receivables | 37,713 | 41,874 | 28,851 | 18,616 | 10,327 |
| Inventories | 19,418 | 10,108 | 5,169 | 4,801 | 4,641 |
| TOTAL | $176,563 | $228,063 | $112,590 | $136,353 | $183,615 |
| Non-Current Assets | |||||
| PPE Net | 6,504 | 5,981 | 5,343 | 5,754 | 5,680 |
| Other Non-Current Assets | 316 | 263 | 263 | 263 | 263 |
| TOTAL | $6,820 | $6,244 | $5,606 | $6,017 | $5,943 |
| Total Assets | $183,383 | $234,307 | $118,196 | $142,370 | $189,558 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 11,458 | 18,769 | 5,337 | 6,315 | 4,477 |
| Accrued Expenses | 30,182 | 35,780 | 23,367 | 21,674 | 17,346 |
| TOTAL | $91,177 | $103,171 | $53,143 | $48,295 | $37,398 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 25,000 | 25,000 | 50,000 |
| Deferred Revenues | N/A | 2,763 | 5,560 | 4,788 | 5,235 |
| TOTAL | $N/A | $N/A | $25,000 | $25,000 | $50,000 |
| Total Liabilities | $91,177 | $103,171 | $78,143 | $73,295 | $87,398 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 71,951 | 64,648 | 54,505 | 54,139 | 53,697 |
| Common Shares | 650 | 646 | 546 | 539 | 537 |
| Retained earnings | -834,147 | -783,455 | -720,965 | -679,099 | -636,300 |
| Other shareholders' equity | -42 | -10 | 0 | -6 | -30 |
| TOTAL | $92,206 | $131,136 | $40,053 | $69,075 | $102,160 |
| Total Liabilities And Equity | $183,383 | $234,307 | $118,196 | $142,370 | $189,558 |